Joshua Budhu, MD

Joshua Budhu, MD is a Clinical Fellow in Neuro-Oncology at Massachusetts General Hospital, the Dana-Farber Cancer Institute, and Brigham and Women's Hospital, Boston, MA. Prior to fellowship, he served as Chief Resident in Neurology at MGH/BWH/HMS, the largest neurology residency in the country. Throughout his education and work experiences, he has demonstrated a commitment to improving health equity. Dr. Budhu aspires to affect change at the policy level through advocacy and awareness and to improve diversity in clinical trials. He serves on several national committees including the Society for Neuro-Oncology’s Women and Diversity Clinical Trials Working Group and the Diversity and Mentorship division of the American Academy of Neurology’s Neuro-Oncology section. He co-authored op-eds for the Washington Post and Brookings Institution, denouncing the pseudoscientic concept “excited delirium”, which misappropriates medical terminology and is used to justify police brutality. He also writes articles for a wide audience about his experience as a physician in training and other health-related matters. Dr. Budhu received his medical degree from Morehouse School of Medicine in 2016.